POINT Biopharma Global Statistics Share Statistics POINT Biopharma Global has 106.57M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 106.57M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 87.47M Failed to Deliver (FTD) Shares 35,048 FTD / Avg. Volume 0.91%
Short Selling Information The latest short interest is 3M, so 2.82% of the outstanding
shares have been sold short.
Short Interest 3M Short % of Shares Out 2.82% Short % of Float 3.32% Short Ratio (days to cover) 1.47
Valuation Ratios The PE ratio is 7.02 and the forward
PE ratio is null.
POINT Biopharma Global's PEG ratio is
-0.03.
PE Ratio 7.02 Forward PE n/a PS Ratio 3.04 Forward PS n/a PB Ratio 1.42 P/FCF Ratio 4.04 PEG Ratio -0.03
Financial Ratio History Enterprise Valuation POINT Biopharma Global has an Enterprise Value (EV) of 403.21M.
EV / Sales 1.78 EV / EBITDA 3.17 EV / EBIT 2.2 EV / FCF 2.36
Financial Position The company has a current ratio of 6.66,
with a Debt / Equity ratio of 0.
Current Ratio 6.66 Quick Ratio 6.59 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is 20.19% and Return on Invested Capital is 19.1%.
Return on Equity 20.19% Return on Assets 17% Return on Invested Capital 19.1% Revenue Per Employee $1.76M Profits Per Employee $761.96K Employee Count 129 Asset Turnover 0.39 Inventory Turnover n/a
Taxes Income Tax 31.29M Effective Tax Rate 24.15%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 0, so POINT Biopharma Global's
price volatility has been lower than the market average.
Beta 0 52-Week Price Change n/a 50-Day Moving Average 13.21 200-Day Moving Average 9.87 Relative Strength Index (RSI) 35.38 Average Volume (20 Days) 3,849,591
Income Statement In the last 12 months, POINT Biopharma Global had revenue of 226.58M
and earned 98.29M
in profits. Earnings per share was 1.04.
Revenue 226.58M Gross Profit 226.58M Operating Income 125.52M Net Income 98.29M EBITDA 127.32M EBIT 128.19M Earnings Per Share (EPS) 1.04
Full Income Statement Balance Sheet The company has 286.43M in cash and 0 in
debt, giving a net cash position of 286.43M.
Cash & Cash Equivalents 286.43M Total Debt n/a Net Cash n/a Retained Earnings 39.01M Total Assets 477.7M Working Capital 314.58M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 183.52M
and capital expenditures -12.77M, giving a free cash flow of 170.75M.
Operating Cash Flow 183.52M Capital Expenditures -12.77M Free Cash Flow 170.75M FCF Per Share 1.8
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of 55.4% and 43.38%.
Gross Margin 100% Operating Margin 55.4% Pretax Margin 57.19% Profit Margin 43.38% EBITDA Margin 56.19% EBIT Margin 55.4% FCF Margin 75.36%
